Is PFS still a relevant endpoint for first-line TKIs?
| Date | 11 April 2018 |
| Event | ELCC 2018 European Lung Cancer Congress |
| Session | First line for oncogene addicted lung cancer |
| Topics | Non-Small-Cell Lung Cancer, Locally Advanced Cancer Immunology and Immunotherapy Lung and other Thoracic Tumours |
| Presenter | Suresh Ramalingam |
| Authors |
S.S. Ramalingam
|